SHWGF (Shandong Weigao Group Medical Polymer Co) Marketable Securities: $125 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHWGF Shandong Weigao Group Medical Polymer Co Ltd SHWGF
57 GF Score
Price $0.43
GF Value $0.79
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shandong Weigao Group Medical Polymer Co Marketable Securities?

Shandong Weigao Group Medical Polymer Co SHWGF 57 Marketable Securities is $125 Mil as of Dec. 2025. GuruFocus rates SHWGF with a GF Score™ of 57/100 and a GF Value™ of $0.79 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Shandong Weigao Group Medical Polymer Co's Marketable Securities for the quarter that ended in Dec. 2025 was $125 Mil.

Shandong Weigao Group Medical Polymer Co's annual Marketable Securities increased from Dec. 2023 ($48 Mil) to Dec. 2024 ($74 Mil) and increased from Dec. 2024 ($74 Mil) to Dec. 2025 ($125 Mil).

Shandong Weigao Group Medical Polymer Co  (OTCPK:SHWGF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Shandong Weigao Group Medical Polymer Co Marketable Securities Related Terms

Shandong Weigao Group Medical Polymer Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Group Medical Polymer Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Group Medical Polymer Co Marketable Securities Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.35 74.82 48.26 74.37 125.38

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.26 46.72 74.37 98.49 125.38
SHWGF
57GF Score
Shandong Weigao Group Medical Polymer Co Ltd SHWGF
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Group Medical Polymer Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $125 Mil mean?
Shandong Weigao Group Medical Polymer Co (SHWGF) has a Marketable Securities of $125 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors.
Is Shandong Weigao Group Medical Polymer Co's Marketable Securities too high?
Shandong Weigao Group Medical Polymer Co's current Marketable Securities is $125 Mil. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's Marketable Securities compare to ISRG and BDX?
Shandong Weigao Group Medical Polymer Co's Marketable Securities of $125 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. Shandong Weigao Group Medical Polymer Co's current Marketable Securities is $125 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.79, compared to a current price of $0.43 — trading 45% below its estimated fair value. The current Marketable Securities is $125 Mil. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGF), the current Marketable Securities is $125 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Weigao Group Medical Polymer Co (SHWGF) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued. The current stock price of $0.43 is trading 45% below its estimated GF Value™ of $0.79. GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.

Key valuation signals for SHWGF:

  • Marketable Securities: $125 Mil
  • GF Value™: $0.79 vs. price of $0.43 (45% below fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the SHWGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Weigao Group Medical Polymer Co Business Description

Address No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
57GF Score

Get the complete analysis for SHWGF

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.43
Price
$0.79
GF Value